CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 77 filers reported holding CULLINAN ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,209 | -67.7% | 7,095 | -61.6% | 0.00% | – |
| Q2 2023 | $198,737 | +38.0% | 18,470 | +31.2% | 0.00% | – |
| Q1 2023 | $143,997 | +59.6% | 14,076 | +64.6% | 0.00% | – |
| Q4 2022 | $90,213 | -19.5% | 8,551 | -2.4% | 0.00% | – |
| Q3 2022 | $112,000 | -10.4% | 8,765 | -10.2% | 0.00% | – |
| Q2 2022 | $125,000 | +25.0% | 9,760 | +1.8% | 0.00% | – |
| Q1 2022 | $100,000 | -39.8% | 9,592 | -11.2% | 0.00% | – |
| Q4 2021 | $166,000 | – | 10,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |